William Blair Issues Negative Outlook for Fortrea Earnings

Fortrea Holdings Inc. (NASDAQ:FTRE) – Equities research analysts at William Blair decreased their Q1 2025 earnings estimates for shares of Fortrea in a research note issued on Monday, March 3rd. William Blair analyst M. Smock now expects that the company will earn ($0.24) per share for the quarter, down from their prior estimate of $0.28. William Blair has a “Market Perform” rating on the stock. The consensus estimate for Fortrea’s current full-year earnings is $0.51 per share. William Blair also issued estimates for Fortrea’s Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at $0.23 EPS, FY2025 earnings at $0.37 EPS, Q1 2026 earnings at ($0.12) EPS, Q2 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.29 EPS, Q4 2026 earnings at $0.40 EPS and FY2026 earnings at $0.67 EPS.

FTRE has been the topic of several other reports. Evercore ISI decreased their price target on shares of Fortrea from $20.00 to $15.00 and set an “in-line” rating on the stock in a research note on Tuesday. Barclays decreased their price target on shares of Fortrea from $25.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Robert W. Baird cut shares of Fortrea from an “outperform” rating to a “neutral” rating and decreased their price target for the stock from $28.00 to $25.00 in a research note on Friday, December 6th. Citigroup lowered shares of Fortrea from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $30.00 to $23.00 in a report on Wednesday, December 11th. Finally, The Goldman Sachs Group cut their price objective on shares of Fortrea from $22.00 to $11.00 and set a “neutral” rating on the stock in a report on Tuesday. One research analyst has rated the stock with a sell rating and eleven have issued a hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $20.30.

Fortrea Price Performance

Fortrea stock opened at $10.69 on Thursday. Fortrea has a 12-month low of $9.55 and a 12-month high of $41.02. The stock has a market capitalization of $958.89 million, a P/E ratio of -3.13, a P/E/G ratio of 1.78 and a beta of 1.34. The firm’s 50-day moving average is $16.50 and its two-hundred day moving average is $18.95. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.18 and a quick ratio of 1.18.

Fortrea (NASDAQ:FTRE) last issued its quarterly earnings data on Monday, March 3rd. The company reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.18). Fortrea had a negative net margin of 10.99% and a positive return on equity of 2.00%. The business had revenue of $697.00 million during the quarter, compared to analyst estimates of $703.22 million. During the same period in the previous year, the company posted $0.19 earnings per share.

Insider Activity at Fortrea

In related news, CEO Thomas Pike sold 11,268 shares of the firm’s stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $18.04, for a total value of $203,274.72. Following the transaction, the chief executive officer now owns 159,868 shares in the company, valued at approximately $2,884,018.72. This trade represents a 6.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Over the last quarter, insiders have sold 12,386 shares of company stock worth $219,751. Company insiders own 0.12% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. Hara Capital LLC acquired a new stake in Fortrea in the third quarter valued at approximately $29,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Fortrea in the fourth quarter valued at approximately $30,000. GF Fund Management CO. LTD. acquired a new stake in Fortrea in the fourth quarter valued at approximately $35,000. Covestor Ltd grew its position in Fortrea by 102.4% in the third quarter. Covestor Ltd now owns 2,763 shares of the company’s stock valued at $55,000 after acquiring an additional 1,398 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in Fortrea by 21.4% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,241 shares of the company’s stock valued at $64,000 after acquiring an additional 572 shares in the last quarter.

Fortrea Company Profile

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.